Geron Corporation (GERN) today announced the appointments of Sharon McBain as Vice President, Global Regulatory Affairs and Lynn Bodarky as Vice ...
Updated: 07/18/2019 04:15P
A California company says its experimental blood test was able to detect many types of cancer at an early stage and gave very few false alarms in a study that included people with and without the disease. Grail gave results in a news release on Friday and will report them Saturday at the American Society of Clinical Oncology meeting in Chicago. They have not been published in a journal or reviewed by other scientists. Many companies are trying to develop early detection "liquid biopsy" tests that capture bits of DNA that cancer cells shed into blood. On Thursday, Johns Hopkins University sc...
Updated: 05/31/2019 09:50A